Urolog. pro Praxi, 2005; 6: 248-252

KIDNEY CANCER EPIDEMIOLOGY

doc. MUDr. Ivan Kawaciuk CSc
Urologická klinika 2. LF UK a FN Motol, Praha

Renal cell carcinoma makes up 2–3 % solid tumors in total in adults. Incidence is 2-fold higher in men in comparison to women, sometimes the ratio is 3:2. The majority of renal cell carcinomas is sporadic, 4 % only is familial. Metastatic disease at the time of diagnosis is found in one third of the patients. In more than half of the patients with localized tumor develop the disease progression in later course of the disease. Renal cell carcinoma is the most lethal urological malignancy, the mortality is > 40 % of patients. The incidence of renal carcinoma has in the last 25 years risen in 23–70 %. Standardized incidence is reported between 2–10 per 100 000 person-years. The Czech republic was in the year 2000 in the first place in the world, the rough incidence was 22.3 per 100 000 person-years (26.,9 in men and 17.9 in women). Mortality in the United States in 1997 was 3.5 per 100 000 person-years, in the Czech Republic in 2000 11.5 per 100 000 person-years, respectively. Incidence of renal cell carcinoma is 10–20 % higher in blacks in comparison to whites, the reason remains unclear. In the last two decades the incidence has risen 3-fold in comparison to mortality. Due to increasing detection of localized incidental tumors the mortality has not increased as much. Down-migration is mainly the result of so far non-systematic screening. Five-years survival has doubled (34 % in 1954 versus 62 % in 1996). The higher survival rate at the end of the 1960s and in the 1970s is due to Robson modification of nephrectomy, in the 1980s due to increased incidence of incidental tumors, respectively. Pilot screening programme study has shown very low capture of renal cell carcinoma in populations with low prevalence. Systematic screening would be more effective if all abdominal organs were examined, not only kidneys. For the time being the screening is limited to target high-risk population.

Keywords: Key words: renal cell carcinoma, epidemiology, incidence, mortality, screening.

Published: January 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kawaciuk I. KIDNEY CANCER EPIDEMIOLOGY. Urol. praxi. 2005;6(6):248-252.
Download citation

References

  1. Bartsch G. Renal cell carcinoma: An introduction. World J Urol, 1984; 2: 87-88. Go to original source...
  2. Bretheau D, Koutani A, Lechevallier E, et al. A French national epidemiologic survey on renal cell carcinoma. Oncology Committee of the Association Française d´Urologie. Cancer, 82, 1998; 3: 538-544. Go to original source...
  3. Devesa SS, Silverman DT, McLaughlin JK, et al. Comparison of the descriptive epidemiology of urinary tract cancers. Cancer Causes Control, 1990; 1: 1133-1141. Go to original source... Go to PubMed...
  4. Filipas D, Spix C, Schultz-Lampel D, et al. Pilot study on early diagnosis of renal cell carcinoma by sonography. Radiologe, 39, 1999; 5: 350-353. Go to original source...
  5. Giuliani L, Martorana G, Giberti C, et al. Results of radical nephrectomy with extensive lymphadenectomy for renal cell carcinoma. J Urol, 1983; 130: 664-668. Go to original source... Go to PubMed...
  6. GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide, Version 1.0. IARC Cancer Base No. 5. Lyon: IARC Press, 2001.
  7. Chow WH, Devesa SS, Warren JL, et al. Rising incidence of renal cell cancer in the United States. JAMA, 1999; 281: 1628-1631. Go to original source... Go to PubMed...
  8. Javadpour N (ed.). Cancer of the kidney. New York : Thieme-Stratton Inc., 1984.
  9. Jayson M, Sanders H. Increased incidence of serendipitously discovered renal cell carcinoma. Urology, 51, 1998; 2: 203-205. Go to original source... Go to PubMed...
  10. Kantor AF. Current concepts in the epidemiology and etiology of primary renal cell carcinoma. J. Urol., 1977; 117: 415-417. Go to original source... Go to PubMed...
  11. Kirkali Z, Tuzel E, Mungan MU. Recent advances in kidney cancer and metastatic disease. BJU Int., 88, 2001; 8: 818-824. Go to original source... Go to PubMed...
  12. Kolcová V, Geryk E, Jechová M. Zhoubné novotvary - Česká republika a vybrané státy. Praha : Galén, 1999, s. 45.
  13. Konnak JW, Grossman HB. Renal cell carcinoma as an incidental finding. J Urol, 1985; 134: 1094-1096. Go to original source... Go to PubMed...
  14. Landis SH, Murray T, Bolden S, et al. Cancer statistics: 1999. CA Cancer J Clin, 1999; 49: 8-31. Go to original source... Go to PubMed...
  15. Lee CT, Katz J, Shi W, et al. Surgical management of renal tumors 4 cm or less in a contemporary cohort. J Urol, 2000; 101: 730-736. Go to original source...
  16. Luciani LG, Cestari R, Tallarigo C. Incidental renal cell carcinoma - age and stage characterization and clinical implications: study of 1092 patients (1982-1987). Urology, 2000; 56: 58-62. Go to original source... Go to PubMed...
  17. Marshall FF, Stewart AK, Menck HR. The National Cancer Data Base: report on kidney cancers. The American College of Surgeons Commission on Cancer and American Cancer Society. Cancer, 88, 1997; č. 11: 2167-2174. Go to original source...
  18. Mihara S, Kuroda K, Yoshioka R, et al. Early detection of renal cell carcinoma by ultrasonographic screening: based on the results of 13 years screening in Japan. Ultrasound Med Biol, 1999; 25: 1033-1039. Go to original source... Go to PubMed...
  19. Pantuck AJ, Zisman A, Belldegrun AS. The changing natural history of renal cell carcinoma. J Urol, 2001; 166: 1611-1623. Go to original source... Go to PubMed...
  20. Parkin DM, Muir CS. Comparability and quality of data. In: Muir C, Waterhous J, Mack T, et al. (eds.): Cancer Incidence in Five Continents. Lyon: IARC Scientific, 1997; 7: 45-46.
  21. Ries LAG, Eisner MP, Kosary CL, et al (eds.). SEER Cancer Statistics Review, 1973-1997. Bethesda, Maryland: National Cancer Institute, 2000.
  22. Robson CJ. Radical nephrectomy for renal cell carcinoma. J Urol, 1963; 89: 37-41. Go to original source... Go to PubMed...
  23. Robson CJ, Churchill BM, Anderson W. The results of radical nephrectomy for renal cell carcinoma. J Urol, 1969; 101: 297-301. Go to original source... Go to PubMed...
  24. Skinner DG, de Kernion JB, et al (eds.). Genitourinary cancer. Philadelphia: WB. Saunders Company, 1978.
  25. Skinner DG, Colvin RB, Vermillion CD, et al. Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer, 1971; 28: 1165-1177. Go to original source...
  26. Spouge AR, Wilson SR, Wooley B. Abdominal sonography in asymptomatic executives: prevalence of pathologic findings, potential benefits, and problems. J Ultrasound Med, 1996; 15: 763-767. Go to original source... Go to PubMed...
  27. Tosaka A, Ohya K, Yamada K, et al. Incidence and properties of renal masses and asymptomatic renal cell carcinoma detected by abdominal ultrasonography. J. Urol., 144, 1990; 5: 1097-1099. Go to original source... Go to PubMed...
  28. Tsuboi N, Horiuchi K, Kimura G, et al. Renal masses detected by general health checkup. Int. J. Urol., 7, 2000; č. 11: 404-408. Go to original source... Go to PubMed...
  29. Tsukamoto T, Kumamoto Y, Yamazaki K, et al. Clinical analysis of incidentally found renal cell carcinomas. Eur. Urol., 1991; 19: 109-113. Go to original source... Go to PubMed...
  30. ÚZIS ČR: Zdravotnická statistika. Novotvary 2000 ČR. Praha, 2004.
  31. Warren M, Kelalis P, Utz D. The changing concept of hypernephroma. J. Urol, 1970; 104: 376-379. Go to original source... Go to PubMed...




Urology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.